| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Levamlodipine besilate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Levamlodipine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely levamlodipine (as levamlodipine besilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levamlodipine (substance) |
Inferred relationship |
Some |
1 |
| Levamlodipine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine (substance) |
Inferred relationship |
Some |
1 |
| Levamlodipine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine (substance) |
Inferred relationship |
Some |
1 |
| Product containing levamlodipine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine (substance) |
Inferred relationship |
Some |
1 |
| Levamlodipine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely levamlodipine (as levamlodipine besilate) 5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levamlodipine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely atenolol 50 milligram and levamlodipine (as levamlodipine besilate) 5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levamlodipine (substance) |
Inferred relationship |
Some |
1 |
| Atenolol and levamlodipine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine (substance) |
Inferred relationship |
Some |
1 |
| Atenolol- and levamlodipine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only atenolol and levamlodipine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely atenolol 50 milligram and levamlodipine (as levamlodipine besilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levamlodipine (substance) |
Inferred relationship |
Some |
1 |
| Atenolol- and levamlodipine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine (substance) |
Inferred relationship |
Some |
1 |
| Hydrochlorothiazide and levamlodipine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine (substance) |
Inferred relationship |
Some |
1 |
| Hydrochlorothiazide- and levamlodipine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine (substance) |
Inferred relationship |
Some |
1 |
| Hydrochlorothiazide- and levamlodipine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine (substance) |
Inferred relationship |
Some |
1 |
| Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levamlodipine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only hydrochlorothiazide and levamlodipine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely levamlodipine (as levamlodipine besilate) 2.5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levamlodipine (substance) |
Inferred relationship |
Some |
1 |
| Product containing levamlodipine and metoprolol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine (substance) |
Inferred relationship |
Some |
1 |
| Levamlodipine and metoprolol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine (substance) |
Inferred relationship |
Some |
1 |
| Product containing levamlodipine and metoprolol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only levamlodipine and metoprolol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely levamlodipine (as levamlodipine besilate) 5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levamlodipine (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]